logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

康宁杰瑞 辉瑞 KN026

Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib)

Mar 30, 2020

强生Covid-19疫苗 紧急使用 疟疾

Healthcare Roundup – J&J picks lead Covid-19 vaccine candidate, FDA OKs emergency use of malaria drugs to treat Covid-19

Mar 30, 2020

Life Science

复星 新冠病毒 核酸检测试剂盒

Fosun Pharma’s Novel Coronavirus Nucleic Acid Detection Kit Receives Emergency Approval from China NMPA

Mar 27, 2020

Life Science

华大基因 新冠病毒试剂 FDA 紧急使用授权

BGI’s Real-Time SARS-CoV-2 Test to Detect Novel Coronavirus Receives FDA Emergency Use Authorization

Mar 27, 2020

Life Science

2.2万亿新冠救助法案 美国 新冠病例

Healthcare Roundup –House passes $2.2T virus relief bill, U.S. takes over top spot in coronavirus cases  

Mar 27, 2020

Life Science

Province’s Essential Services Declaration for Food Industry to maintain BC’s Food Supply Chain

Mar 27, 2020

Life Science

阿里巴巴发起的“全球新冠肺炎实战共享平台”

Global Medical Institutions Scramble to Join Alibaba’s Covid-19 Insight-Sharing Platform

Mar 27, 2020

Life Science, Technology

特朗普 20国集团 Covid-19 新冠病毒 TherapeuticsMD

Healthcare Roundup –Trump says G-20 nations coordinating on Covid-19, TherapeuticsMD suspends guidance due to Covid-19

Mar 27, 2020

Life Science

Mylan 辉瑞 Upjohn 新冠病毒

Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic

Mar 26, 2020

Life Science

迈兰 克力芝 吉利德 孤儿药 瑞德昔韦

Healthcare Roundup – Mylan waives exclusive U.S. rights to generic Kaletra, Gilead to withdraw Orphan Drug tag for remdesivir

Mar 25, 2020

Life Science

Sorrento 迈博药业 新冠病毒 新冠肺炎

Sorrento Collaborates with Mabpharm on Development and Commercialization of Ace-Mab™ to Potentially Treat COVID-19

Mar 25, 2020

Life Science

吉利德瑞德昔韦将委托中国企业制造,复制瑞德昔韦属谣言

Gilead Mulls Hiring Remdesivir OEMs in China if Drug Passes Clinical Trials

Mar 25, 2020

Life Science

特朗普 恢复营业 新冠病毒

Healthcare Roundup –Trump would like country open for business by Easter Sunday, U.S. coronavirus cases near 47K

Mar 24, 2020

Life Science

来凯 诺华 FAZ053

Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset

Mar 24, 2020

Life Science

Dynavax 三叶草 新冠病毒

Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant

Mar 24, 2020

Life Science

Naturally Splendid Provides Further Facility Preparation Update

Mar 24, 2020

Life Science

乐普医疗AI-ECG Tracker

Lepu Medical Technology’s AI-ECG Tracker Gains US FDA’s Seal

Mar 24, 2020

Life Science

吉利德 瑞德昔韦 COVID-19 新冠病毒 疟疾药物

Healthcare Roundup – Gilead’s remdesivir wins orphan drug status for coronavirus, New York launches use of malaria drug to treat Covid-19

Mar 23, 2020

Life Science

  • ‹‹ Previous
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada